Allergan (NYSE: AGN) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced that Allergan has acquired rights to CONSTELLA (linaclotide) in the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Management Comments Mergers and Acquisitions

Leerink PartnersRaises Price Target on Allergan (AGN) Following a MEDACorp Survey October 28, 2015 7:05 AM Allergan Acquires Rights To Ironwood's CONSTELLA® (Linaclotide) From Almirall In More Than 40 CountriesOctober 27, 2015 3:30 AM Controversial pharma CEO Martin Shkreli bails on Valeant betOctober 26, 2015 6:38 PM